483
Guangzhou Baiyunshan Jingxiutang Pharmaceutical Co. Ltd.Guangzhou Baiyunshan Jingxiutang Pharmaceutical Co. Ltd. – FDA 483, Dec 8, 2023
Record Details
An FDA inspection of Guangzhou Baiyunshan Jingxiutang Pharmaceutical Co. Ltd., an OTC human drug manufacturer, revealed significant deficiencies in laboratory controls, including a repeat observation regarding active ingredient testing and inadequate microbial testing of the water system. Additionally, the firm failed to provide continuous GMP training to employees on US regulatory requirements, specifically 21 CFR Parts 210 and 211.
- Inspection date
- December 8, 2023
- Product type
- drugs
View Company Profile
ID · 5a459c98-5659-41ba-9a22-cd027b5cc931
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.